Master your fundamental research. Join 78,694 investors who trust our platform and content.
Save 54+ hours of fundamental research with free access to Stock Card.
We only ask your name and email address.
First up is Shopify (Ticker: SHOP).
It all started when we were talking about Shopify and how the company has recovered from its significant price-fall that occurred as the result of Citron research incident. Citron is a research company famous for its now-and-then controversial claims about one of the more popular stocks. In late 2017, Citron claimed that Shopify is not a reliable business and operates more like a Ponzi scheme. Shopify share price fell as if it was hit by a lightning strike. However, the company has recovered from those dark days, and following its recent positive quarterly earnings, it is now continuing its climb towards the sky. Sure, the stock is expensive but so is every small and nifty company that is growing rapidly and claiming a big chunk of a significantly large market. Investing in Shopify is similar to venture capitalist type of investing where the risk is high, but the reward is high too. As long as the reasons to invest are well-understood and backed by facts and logic, it can be worthy for a risk-taker type of investor.
Next one is not too far from Shopify; it's Baozun! (Ticker: BZUN).
It's a Shopify-equivalent in China and our Facebook group members could not stop raving about it. Our community has argued that Baozun is much bigger and stronger than Shopify. While SHOP is focused on the software behind running an online commerce business by small and medium-sized companies, Baozun is serving the big and small alike. Some 150 global brands such as Nike and Microsoft are using the platform to enter the Chinese market and the company runs everything for them, from software to fulfillment of the orders. This is a company that can be potentially much larger than some of the big players, such as Alibaba, in the Chinese ecommerce market.
Next one is Aurora Cannabis (Ticker: ACB.TO).
When there is an acquisition, there is always excitement. This week, Aurora Cannabis announced its plan to acquire MedReleaf. This is a Canadian cannabis company. Aurora Cannabis seeks to be 'Amazon' of marijuana. The acquisition gives ACB access to four additional geographical markets. The current deal already makes it 'Canada's leading marijuana company'. As per its Founder and CEO Terry Booth, Aurora Cannabis has plans for further expansion through acquisitions. Have a look at the company's Stock Card to see a few pros and cons of investing in it.
This week, Stock Card Premium members received their exclusive investment pick of the week on Wednesday. We talked about a stock that benefits our hairy babies. You should consider joining us in the fun! Every Wednesday, we share the latest addition to our portfolios and share our detailed analysis with our Stock Card Premium members. Also, Stock Card Premium members have access to Stock Card investment ideas and three Stock Card requests per month to validate their own investment ideas.